Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

In 2025, FDA’s import enforcement posture around Foreign Supplier Verification Programs (FSVP) has become much less forgiving—especially for imported botanical extracts and concentrates that are marketed as “hemp-derived” ingredients (including CBD, minor cannabinoids, and nanoemulsified preparations). Even though the broader federal policy questions about CBD in conventional foods remain unresolved, FDA has continued to treat the import side as a clear compliance lane: if you import an ingredient that is a food (or will become a food ingredient), you must meet 21 CFR Part 1, Subpart L.
For beverage brands and co-packers, the practical message is straightforward:
This post is informational only and not legal advice.
FSVP is the FSMA-era rule that makes the U.S. importer responsible for ensuring foreign-supplied food is produced in a manner that provides the same level of public health protection as U.S. requirements, and that the food is not adulterated or misbranded with respect to allergen labeling.
FSVP’s core requirements (at a high level) include:
Official references:
Under FSVP, the “importer” is generally the U.S. owner or consignee of the food at the time of entry. If there is no U.S. owner or consignee, the U.S. agent/representative of the foreign owner/consignee can be the FSVP importer.
Why this matters in 2025: FDA warning letters and import entry reviews frequently highlight situations where firms cannot clearly identify:
Beverage brands that “never touch the ingredient” (because a co-packer or broker arranges drop shipment) can still end up as the FSVP importer if they are the U.S. owner/consignee.
If you are manufacturing a conventional beverage in the U.S., the facility is typically subject to 21 CFR Part 117 (Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food), unless a specific exemption applies.
Relevant Part 117 concepts that often overlap with FSVP work:
Part 117 reference: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-117
Practical takeaway: Don’t treat FSVP as “the importer’s paperwork” and Part 117 as “the plant’s paperwork.” FDA inspectors may expect alignment between:
Some ingestible products are marketed as dietary supplements even when they look like beverages. If your finished product meets the legal definition of a dietary supplement and is labeled as such, 21 CFR Part 111 (dietary supplement CGMP) can apply.
Part 111 reference: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
Part 111 has a strong focus on:
Important: Whether a cannabinoid-containing ingestible can lawfully be marketed as a dietary supplement is a separate federal legal question; this post focuses on the FSVP/import and manufacturing compliance mechanics.
FDA continues to post FSVP warning letters (across many categories), and the recurring FSVP gaps that matter most for imported cannabinoid ingredients used in beverages tend to cluster in a few buckets.
Use FDA’s warning letter database and filter by “FSVP” to see current postings: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
For hemp-derived distillates, isolates, and nanoemulsions, the hazard analysis often needs to address chemical hazards that are common for botanical extracts and concentrate-type ingredients.
FDA commonly expects the hazard analysis to consider, as applicable:
When firms rely solely on a supplier COA without documenting the hazard evaluation logic, it can look like they skipped the required analysis.
FSVP verification is not “one size fits all.” FDA expects verification activities to be risk-based and tied to the hazard analysis.
Common verification activities include:
When the imported input is a high-value, high-concentration ingredient that will be used in a ready-to-consume beverage, FDA may expect more than periodic COAs.
FSVP inspections are document-driven. A frequent failure mode is simply not being able to produce:
If your brand uses a broker, freight forwarder, or co-packer, you still need written clarity about where the FSVP records live and how fast you can access them.
A practical enforcement trigger is when entry information is inconsistent or incomplete.
Brands should watch for:
These issues can create avoidable delays and elevate scrutiny.
Even if you have strong FSVP documentation, certain attributes can raise the odds of shipment holds:
FDA’s import enforcement toolbox includes examinations, sampling, and Detention Without Physical Examination (DWPE) through Import Alerts.
FDA Import Alert database: https://www.accessdata.fda.gov/cms_ia/ialist.html
Compliance takeaway: If your ingredient category is already prone to heightened attention, the cost of “documentation gaps” is higher—because you may need those records to respond rapidly during an admissibility challenge.
Beverage brands often buy cannabinoid ingredients through complex channels (foreign manufacturer → trader → U.S. broker → co-packer). Under FSVP, you need enough documentation to support both supplier approval and ongoing verification.
Below is a practical, audit-ready set of documents to request and maintain.
COAs should be lot-specific and tied to validated/fit-for-purpose methods.
Ask for:
Tip: If you are relying on supplier COAs as a key control, your program should document why that reliance is appropriate, and how you confirm COA integrity (e.g., periodic third-party verification testing).
Depending on risk, assemble:
A frequent 2025 risk scenario is a “drop-ship” model:
If your co-packer is named as the FSVP importer at entry, that co-packer must have a compliant FSVP. Many co-packers are surprised by this during an FDA inspection.
Use this as a practical internal control list.
If you are importing or planning to import hemp-derived ingredients in 2026 planning cycles, take these steps immediately.
Many beverage teams assume that if they have strong FSVP records and contaminant testing, they are “cleared” federally. In practice, there are two separate layers:
A mature compliance program addresses both—but FSVP is the piece that can stop your supply chain immediately at the border.
If your supply chain includes imported distillates, isolates, or emulsified ingredients, use CannabisRegulations.ai to centralize your cannabis compliance documentation, map responsibilities across brands and co-packers, and stay current on evolving licensing and regulations that affect product development and distribution. Get started at https://cannabisregulations.ai/